Form 4: Maravai LifeSciences Executive Christine Dolan Reports Stock Transaction
SEC Form 4
Christine Dolan, an executive at Maravai LifeSciences, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On January 15, 2025, Christine Dolan, an Executive Vice President & General Manager at Maravai LifeSciences Holdings, Inc., had 28,704 shares of Class A Common Stock withheld to cover tax obligations.
- The shares were withheld at a price of $4.56 per share.
- Following the transaction, Dolan beneficially owns 231,634 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard tax withholding transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax withholding event.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Date of stock transaction (tax withholding) |
| 01/17/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.